Blog

■ Updates in diagnosis and treatment of acromegaly

Roula Zahr, Maria Fleseriu

Eur Endocrinol. 2018 Sep; 14(2): 57–61

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6182922/

 

■ Insulin resistance in patients with acromegaly

Greisa Vila, Jens Otto L. Jørgensen, Anton Luger, Günter K. Stalla

Front Endocrinol (Lausanne) 2019; vol 10: 509

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6683662/

 

■ Neoplasias malignas en acromegalia

S Sosa, K Danilowicz, R M Gómez

Rev Argent Endocrinol Metab 2018, vol 55 (4): 240-246

http://www.raem.org.ar/numeros/2018-vol55/numero-04/vol55-04-006.pdf

 

■ Hearing Loss in Acromegaly – A Review

Teixeira, Liane Sousa et al.

Int. Arch. Otorhinolaryngol., July 2018, vol.22, no.3, p.313-316

http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1809-48642018000300313&lng=en&nrm=iso

 

■ Bringing cardiovascular comorbidities in acromegaly to an update. How should we diagnose and manage them?

Ana M. Ramos-Leví, Mónica Marazuela

Front Endocrinol (Lausanne) 2019; vol 10: 120.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6423916/

 

■ Hepatic steatosis in patients with acromegaly

Andreani Koutsou‐Tassopoulou, Ifigeneia Papapostoli‐Sklavounou, Marcin Krawczyk, et al

Endocrinol Diabetes Metab. 2019 Oct; 2(4): e00090

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6775446/

 

■ The endothelium in acromegaly

Pietro Maffei, Francesca Dassie, Alexandra Wennberg, et al

Front Endocrinol (Lausanne) 2019; vol 10: 437

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6667653/

 

■ Actions of pituitary hormones beyond traditional targets

Mone Zaidi, Maria I. New, Harry C. Blair et al

J Endocrinol. 2018 Jun; 237(3): R83–R98

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5924585/

 

■ Emerging and novel treatments for pituitary tumors

Mirela Diana Ilie, Hélène Lasolle, Gérald Raverot

J Clin Med. 2019, vol 8(8): 1107

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6723109/

 

■ Pediatric pituitary adenoma: case series, review of the literature, and a skull base treatment paradigm

Avital Perry, Christopher Salvatore Graffeo, Christopher Marcellino et a

J Neurol Surg B Skull Base. 2018 Feb; 79(1): 91–114

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5796823/

 

■ Pituitary disease in pregnancy: special aspects of diagnosis and treatment

Stephan Petersenn, Mirjam Christ-Crain, Michael Droste et al

Geburtshilfe Frauenheilkd. 2019, vol 79(4): 365–374

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6461462/

 

■ Hypopituitarism after orthohantavirus infection: What is currently known?

Soerajja Bhoelan, Thomas Langerak, Danny Noack, et al

Viruses. 2019, vol 11(4): 340

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6521286/

 

■ Neonatal hypopituitarism: approaches to diagnosis and treatment

Selim Kurtoğlu, Ahmet Özdemir, Nihal Hatipoğlu

J Clin Res Pediatr Endocrinol. 2019, vol 11(1): 4–12

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6398195/

 

■ Staging and managing patients with acromegaly in clinical practice: baseline data from the SAGIT validation study

A Giustina, M D Bronstein, P Chanson et al

Pituitary 2019, vol 22 (5): 476-487

https://link.springer.com/article/10.1007/s11102-019-00977-5

 

■ Clinical and hormonal characteristics of patients with different types of hypophysitis: a single-center experience

Imga, Narin Nasiroglu et al.

Arch. Endocrinol. Metab., Jan 2019, vol.63, no.1, p.47-52

http://www.scielo.br/scielo.php?script=sci_arttext&pid=S2359-39972019000100047&lng=en&nrm=iso

 

■ Combined pituitary hormone deficiency caused by PROP1 mutations: update 20 years post-discovery

F A Correa, M Nakagurna, J L O Madeira et al

Arch Endocrinol Metab 2019, vol63 (2)

http://www.scielo.br/scielo.php?script=sci_arttext&pid=S2359-39972019000200167

 

■ Clinical and pathological aspects of silent pituitary adenomas

Juliana Drummond, Federico Roncaroli, Ashley B Grossman, Márta Korbonits

J Clin Endocrinol Metab. 2019, vol 104(7): 2473–2489

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6517166/

 

■ Functionin pituitary adenomas – current treatment options and emerging medical therapies

Elena V Varlamov, Shirley McCartney, Maria Fleseriu

Eur Endocrinol. 2019 Apr; 15(1): 30–40.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6587904/

 

■ Non-functioning pituitary adenomas: indications for pituitary surgery and post-surgical management

Daniela Esposito, Daniel S. Olsson, Oskar Ragnarsson et al

Pituitary. 2019; vol 22(4): 422–434

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6647426/

 

■ Prolactina como immunomodulador en las enfermidades autoimunes

C Pissoni, L Nieto, m Raã et al

Rev Argent Endocrinol Metab 2019, vol 56#2

http://www.raem.org.ar/numeros/2019-vol56/numero-02/raem-56-2-43-48.pdf

 

■ Serum prolactina and bone mineral density in schizophrenia: a systematic review

John Lally, Abdullah Bin Sahl, Kieran C. Murphy et al

Clin Psychopharmacol Neurosci. 2019, vol 17(3): 333–342

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6705095/

 

■ Serum prolactina overestimation and risk of misdiagnosis

Sunita M.C. De Sousa, Mohamed Saleem, Wayne Rankin, David J. Torpy

Endocrinol Diabetes Metab. 2019, vol 2(3): e00065.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6613232/

 

■ A systematic review of cortisol, thyroid stimulating hormone and prolactin in periperipartum women with major depression

Mercedes J. Szpunar, Barbara L. Parry

Arch Womens Ment Health. 2018 Apr; 21(2): 149–161

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5857206/

 

■ Prolactin concentration in various stages of endometriosis in infertile women

Parvaneh Mirabi, Seyede Hanie Alamolhoda, Masoumeh Golsorkhtabaramiri, Mahshid Namdari, Sedighe Esmaeilzadeh

JBRA Assist Reprod. 2019, vol 23(3): 225–229

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6724390/

 

■ Clinical manifestations, evaluation and management of hyperprolactinemia in adolescent and young girls: a brief review

Matalliotakis Michail, Koliarakis Ioannis, Matalliotaki Charoula, Trivli Alexandra, Hatzidaki Eleftheria

Acta Biomed. 2019; vol 90(1): 149–157

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6502148/

 

■ PCOS and hyperprolactinemia: What do we know in 2019

Clémence Delcour, Geoffroy Robin, Jacques Young, Didier Dewailly

Clin Med Insights Reprod Health. 2019; 13: 1179558119871921

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6734626/

 

■ Stress-induced hyperprolactinemia: pathophysiology and clinical approach

Samara Levine, Ozgul Muneyyirci-Delale

Obstet Gynecol Int. 2018; 2018: 9253083.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6304861/

 

■ Genetic causes of isolated short stature

Vasques, Gabriela A., Andrade, Nathalia L. M. and Jorge, Alexander A. L

Arch. Endocrinol. Metab., Jan 2019, vol.63, no.1, p.70-7

http://www.scielo.br/scielo.php?script=sci_arttext&pid=S2359-39972019000100070

 

■ Growth hormone deficiency following traumatic brain injury

Oratile Kgosidialwa, Osamah Hakami, Hafiz Muhammad Zia-Ul-Hussnain, Amar Agha

Int J Mol Sci. 2019, vol 20(13): 3323

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6651180/

 

■ Growth hormone (GH) therapy during the transition period: Should we think about early retesting in patiens with idiopathic and isolated GH deficiency?

Laura Penta, Marta Cofini, Laura Lucchetti et al

Int J Environ Res Public Health. 2019, vol 16(3): 30

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6388362/

 

■ Targeting growth hormone function: strategies and therapeutic applications

Man Lu, Jack U. Flanagan, Ries J. Langley, Michael P. Hay, Jo K. Perry

Signal Transduct Target Ther. 2019; 4: 3

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6367471/

 

■ The potential effects of anabolic-androgenic steroids and growth hormone as commonly used sport supplements on the kidney: a systematic review

Dorna Davani-Davari, Iman Karimzadeh, Hossein Khalili

BMC Nephrol. 2019; vol 20: 198

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6545019/

 

■ Use of growth hormone in the IVF treatment of women with poor ovarian reserve

Roger J. Hart

Front Endocrinol (Lausanne) 2019;  vol 10: 500

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6667844/

 

■  Dr Paulo Fernando Leite

Cardiologia/Prevenção Cardiovascular

Estratificação de Risco Cardiovascular

Consultório: Rua Padre Rolim 815/sala 601

Tel: 33245518

CRMMG: 7026

Email: pfleite1873@gmail.com

Data: nov 2019

■ Cardiovascular risk in type 1 diabetes mellitus

Jonathan Schofield, Jan Ho, Handrean Soran

Diabetes Ther. 2019 Jun; 10(3): 773–78

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6531592/

 

■ The early detection of atherosclerosis in type 1 diabetes: why, how and what to do about it

Alicia Jenkins, Andrzej Januszewski, David O’Neal

Cardiovasc Endocrinol Metab. 2019, vol 8(1): 14–27

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6739889/

 

■ Recent trends over time in vascular disease in type 1 diabetes: insights from the Pittsburg Epidemiology of Diabetes Complications study

Tina Costacou, Trevor J. Orchard

Cardiovasc Endocrinol Metab. 2019 Mar; 8(1): 3–13

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6739893/

 

■ Type 1 diabetes mellitus and coronary revascularization

Helene Mamet, Mark C. Petrie, Paul Rocchiccioli

Cardiovasc Endocrinol Metab. 2019 Mar; 8(1): 35–38

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6739890/

 

■ Vascular disease in the lower limb in type 1 diabetes

Michael Edmonds

Cardiovasc Endocrinol Metab. 2019 Mar; 8(1): 39–46

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6739894/

 

■ Psicologia e adolescentes com diabetes mellitus tipo 1: uma revisão sistemática

L C M Ribeiro, R L dos Santos Aléssio, B S Almeida

Adolescencia & Saúde 2018, vol 15 (3)

http://www.adolescenciaesaude.com/detalhe_artigo.asp?id=739

 

■ Prediction and prevention of type 1 diabetes in children

Francesco Chiarelli, Cosimo Giannini, Marina Primavera

Clin Pediatr Endocrinol. 2019; 28(3): 43–57

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6646239/

 

■ A review of insulin resistance in type 1 diabetes: Is there a place for adjunctive metformin?

Gagan Priya, Sanjay Kalra

Diabetes Ther. 2018 Feb; 9(1): 349–361

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5801219/

 

■ Fast-acting insulin aspart: the rationarle for a new mealtime insulin

Marc Evans, Mathew Wilkinson, Angeliki Giannpolou

Diabetes Ther. 2019 Oct; 10(5): 1793–1800

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6778592/

 

■ A review of the safety and adverse event profile of the fixed-ratio combination of insulin glargine and lixisenatide

Juan P. Frias, Terry Dex, Michelle Roberts, Allen Kaplan

Diabetes Ther. 2019 Feb; 10(1): 21–33

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6502244/

 

■ Partial clinical remission of type 1 diabetes mellitus in children: clinical application and challenges with its definitions

Benjamin Udoka Nwosu

Eur Med J Diabetes. 2019, vol 4(1): 89–98

https://www.emjreviews.com/diabetes/article/partial-clinical-remission-of-type-1-diabetes-mellitus-in-children-clinical-applications-and-challenges-with-its-definitions/

 

■ Immunomodulatory effect of vitamin D and its potential role in the prevention and treatment of type 1 diabetes mellitus – a narrative review

Karolina Rak, Monika Bronkowska

Molecules. 2019, vol 24(1): 53

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6337255/

 

■ Genetic aspects of type 1 diabetes

Hae Sang Lee, Jin Soon Hwang

Ann Pediatr Endocrinol Metab. 2019, vol 24(3): 143–148

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6790877/

 

■ Is there any association between gut microbiota and type 1 diabetes?

Parnian Jamshidi, Saba Hasanzadeh, Azin Tahvildari et al

Gut Pathog. 2019; vol 11: 49

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6791003/

 

■ Environmental factors associated with type 1 diabetes

Susanna Esposito, Giada Toni, Giorgia Tascini, Elisa Santi, Maria Giulia Berioli, Nicola Principi

Front Endocrinol (Lausanne) 2019; vol 10: 592

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6722188/

 

■ Immune chekpoint inhibitor-induced type 1 diabetes: a systematic review and meta-analysis

1. K. Akturk, D. Kahramangil, A. Sarwal et al

Diabet Med. 2019, vol 36(9): 1075–1081

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6698212/

 

■ Type 1 diabetes

Linda A DiMeglio, Carmella Evans-Molina, Richard A Oram

Lancet. 2018 Jun 16; 391(10138): 2449–2462

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6661119/

 

■  Dr Paulo Fernando Leite

Cardiologia/Prevenção Cardiovascular

Estratificação de Risco Cardiovascular

Consultório: Rua Padre Rolim 815/sala 601

Tel: 33245518

CRMMG: 7026

Email: pfleite1873@gmail.com

Data: nov 2019